Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
Inflammatory Bowel Diseases · 2024
DOI: 10.1093/ibd/izad278 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Katie Ann Dunleavy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Proctocolectomy, Restorative, Colectomy, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Background
Patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC) frequently undergo restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for medically refractory disease or colonic dysplasia/neoplasia. Subtotal colectomy with ileosigmoid or ileorectal anastomosis may have improved outcomes but is not well studied. Due to increased risk for colorectal cancer in PSC-IBD, there is hesitancy to perform subtotal colectomy. We aim to describe the frequency of colorectal dysplasia/neoplasia following IPAA vs subtotal colectomy in PSC-IBD patients.
Methods
We completed a retrospective study from 1972 to 2022 of patients with PSC-IBD who had undergone total proctocolectomy with IPAA or subtotal colectomy. We abstracted demographics, disease characteristics, and endoscopic surveillance data from the EMR.
Results
Of 125 patients (99 IPAA; 26 subtotal), the indication for surgery was rectal sparing medically refractory disease (51% vs 42%), dysplasia (37% vs 30%) and neoplasia (11% vs 26%) in IPAA vs subtotal colectomy patients, respectively. On endoscopic surveillance of IPAA patients, 2 (2%) had low-grade dysplasia (LGD) in the ileal pouch and 2 (2%) had LGD in the rectal cuff after an average of 8.4 years and 12.3 years of follow-up, respectively. One (1%) IPAA patient developed neoplasia of the rectal cuff after 17.8 years of surgical continuity. No subtotal colectomy patients had dysplasia/neoplasia in the residual colon or rectum.
Conclusions
In patients with PSC-IBD, there was no dysplasia or neoplasia in those who underwent subtotal colectomy as opposed to the IPAA group. Subtotal colectomy may be considered a viable surgical option in patients with rectal sparing PSC-IBD if adequate endoscopic surveillance is implemented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
- Department of Gastroenterology, Galway University Hospital, Galway, Ireland.
- Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
- Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA.
ORCID-Profile: Priscila Santiago, Nicholas P McKenna, Nayantara Coelho-Prabhu, Laura Raffals
Zitieren
APA
Dunleavy, K. A., Santiago, P., Forde, G., Harmsen, W. S., McKenna, N. P., Coelho-Prabhu, N., Shawki, S., & Raffals, L. (2024). Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad278
Vancouver
Dunleavy KA, Santiago P, Forde G, Harmsen WS, McKenna NP, Coelho-Prabhu N, et al. Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad278
BibTeX
@article{Dunleavy2024,
author = {Dunleavy, Katie Ann and Santiago, Priscila and Forde, Gerard and Harmsen, W Scott and McKenna, Nicholas P and Coelho-Prabhu, Nayantara and Shawki, Sherief and Raffals, Laura},
title = {Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis},
journal = {Inflammatory Bowel Diseases},
year = {2024},
doi = {10.1093/ibd/izad278}
}
EUVIMED